Portfolio manager highlights AbbVie, Pfizer and Medtronic as compelling large-cap health care dividend plays with growth and ...
AbbVie dips below its 50-day SMA, but strong immunology momentum and a resilient long-term trend keep the story compelling.
MarketBeat on MSN
Dividend powerhouses: 3 blue-chip stocks built for the long haul
The wall of worry continues to grow as investors race into 2026. Concentration risk is one that may not get talked about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback